SNIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.532200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.317000E-01
Normal-vs-Stage2
3.561600E-01
Normal-vs-Stage3
8.053900E-02
Normal-vs-Stage4
5.743200E-01
Stage1-vs-Stage2
6.107200E-01
Stage1-vs-Stage3
1.349430E-01
Stage1-vs-Stage4
2.577200E-01
Stage2-vs-Stage3
1.668550E-01
Stage2-vs-Stage4
6.346000E-02
Stage3-vs-Stage4
2.598300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.487200E-01
Normal-vs-AfricanAmerican
9.202400E-01
Normal-vs-Asian
1.462200E-01
Caucasian-vs-AfricanAmerican
2.603800E-01
Caucasian-vs-Asian
2.673400E-01
AfricanAmerican-vs-Asian
1.152820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.241800E-01
Normal-vs-Female
4.103800E-01
Male-vs-Female
2.829000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.912600E-01
Normal-vs-Age(41-60Yrs)
7.134400E-01
Normal-vs-Age(61-80Yrs)
2.709200E-01
Normal-vs-Age(81-100Yrs)
7.130000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.128400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.703800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.697800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.859100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.041200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.837790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.480100E-02
Normal-vs-Daily Drinker
1.904760E-01
Normal-vs-Weekly Drinker
2.113600E-01
Normal-vs-Occasional Drinker
8.864800E-01
Normal-vs-Social Drinker
4.942000E-01
Non Drinker-vs-Daily Drinker
4.927000E-01
Non Drinker-vs-Weekly Drinker
4.907600E-01
Non Drinker-vs-Occasional Drinker
2.183200E-03
Non Drinker-vs-Social Drinker
3.854000E-02
Daily Drinker-vs-Weekly Drinker
9.427600E-01
Daily Drinker-vs-Occasional Drinker
2.688100E-02
Daily Drinker-vs-Social Drinker
1.933230E-01
Weekly Drinker-vs-Occasional Drinker
5.368000E-02
Weekly Drinker-vs-Social Drinker
2.568400E-01
Occasional Drinker-vs-Social Drinker
3.664200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.944580E-01
Normal-vs-Grade 2
1.126340E-02
Normal-vs-Grade 3
2.506200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.998200E-01
Grade 1-vs-Grade 3
5.517200E-01
Grade 1-vs-Grade 4
1.944580E-01
Grade 2-vs-Grade 3
7.101600E-01
Grade 2-vs-Grade 4
1.126340E-02
Grade 3-vs-Grade 4
2.506200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.370570E-01
Normal-vs-NonDiabetic
2.576000E-01
Diabetic-vs-NonDiabetic
2.890800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.414400E-01
Normal-vs-NoPancreatitis
2.376200E-01
Pancreatitis-vs-NoPancreatitis
4.487200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.286200E-01
Normal-vs-N1
3.870400E-01
N0-vs-N1
5.985800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.110000E-01
Normal-vs-TP53-NonMutant
5.314600E-01
TP53-Mutant-vs-TP53-NonMutant
9.376800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
